# Dianthus Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2022

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 10-K/A
- Filed: 2023-05-01
- Accepted by EDGAR: May 1, 2023, 08:31 ET
- Period: 2022-12-31
- Accession: 0001193125-23-128874
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312523128874/d213578d10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312523128874/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312523128874/d213578d10ka.htm

Filed May 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-128874. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.
